Overview - Managing Nicotine Withdrawal in Medically Ill Patients

Activity Details
  • Credit Type: Other
  • Credit Amount: 1.00
  • Cost: Free
  • Release: Jun 16, 2016
  • Expires: Jan 1, 2018
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Faculty

Audrey Darville Audrey Darville, PhD, APRN, CTTS
Certified Tobacco Treatment Specialist
UK Healthcare
Assistant Professor
University of Kentucky College of Nursing
Lexington, Kentucky

Angela Tackett Dearinger Angela Tackett Dearinger, MD, MPH, FACP, FAAP
Associate Professor, Internal Medicine
Assistant Dean, Accreditation, GME
University of Kentucky College of Medicine
Associate Professor, Health Services Management
University of Kentucky College of Public Health
Lexington, Kentucky

Needs Statement

Globally, tobacco use is the leading cause of preventable death. Despite this, a recent evaluation of the National Health Interview Survey (Kruger, Shaw, Kahende & Frank, 2012) found that healthcare providers are becoming less likely to advise their patients to quit smoking, although nearly 68% of smokers want to quit. In Kentucky tobacco use prevalence rates among adults are the highest in the nation.

Nicotine replacement is underutilized in medically ill patients. Yet there is strong evidence to support its use in improving symptoms of nicotine withdrawal and promoting tobacco use cessation.

Target Audience

Health care providers who manage patients with tobacco dependence in medical and surgical specialty settings.

Objectives

At the end of the session, the participant will be able to:

1. Recognize the impact of nicotine withdrawal on patient comfort and outcomes
2. Describe five symptoms of nicotine withdrawal
3. Identify nicotine withdrawal treatment options including dosing strategies and potential side effects
4. Review current Clinical Practice Guidelines and evidence-based recommendations for treating tobacco dependence

Accreditation

Other
UK Healthcare CECentral certifies this activity for 1.00 hour of participation.

Faculty Disclosure

Audrey Darville, PhD, APRN, CTTS (speaker) has received partial salary support from an unrestricted Pfizer Medical Education Grant in collaboration with the Smoking Cessation Leadership Center for the purpose of developing and producing these modules. She has no other relevant financial relationships with commercial interests. 

Angela Dearinger, MD, MPH, FAAP (speaker) has received partial salary support from an unrestricted Pfizer Medical Education Grant in collaboration with the Smoking Cessation Leadership Center for the purpose of developing and producing these modules. She has no other relevant financial relationships with commercial interests. 

Dr. Darville & Dr. Dearinger will discuss off label use of a product.

No other authors, planners or content reviewers have any relevant financial relationships to disclose. 

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation

CE Content Concerns

Policy

Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504

Procedures

  • The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
  • If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
  • Issues regarding activity content also will be reviewed and addressed by the Activity Director.
  • A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
  • Grievances will be considered when planning future activities.

Appeal Procedure

  • Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
  • The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
  • The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.